Food and Drug Administration–Approved Fecal Microbiota–Based Therapies for Recurrent Clostridioides difficile Infection

Gastroenterology Clinics of North America · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles